Find here vacant position at LDRI or elsewhere.
June 28, 2022
For the DI-PRESCRIBE project, TFAR/CLIP is looking for 1 post-doctoral research fellow, for a duration of 2 years.
Starting date: October 1, 2022.
Research will be conducted at UCLouvain Brussels Woluwe and Louvain-la-Neuve (convenient and rapid commute with public transport).
Detailed description is provided for each profile here.
June 10, 2022
Postdoctoral position in food intake disorders and gut microbiota at MNut group (LDRI)
June 9, 2022
PhD in pharmaceutical and biomedical sciences in the group of experimental and clinical pharmacology (LDRI - TFAR), 4 years – supervision by Joseph H. Lorent (PhD).
Bacterial membrane domains as targets in antibiotic resistance.
Detailed information here.
May 18, 2022
Two PhD Thesis offers in pulmonary delivery of biomolecules: LDRI-UCLouvain and UCLouvain - Astra Zeneca
May 5, 2022
Postdoctoral position at Utrecht University, beginning August or September 2022.
Information here.
Contact: j.h.f.f.lorent@uu.nl
May 31, 2022
For the DI-PRESCRIBE project, TFAR/CLIP is looking for:
- 1 junior research fellows, each for 4 years
- 1 post-doctoral research fellow, for a duration of 2 years
Starting date: October 1, 2022.
Research will be conducted at UCLouvain Brussels Woluwe and Louvain-la-Neuve (convenient and rapid commute with public transport).
Detailed description is provided for each profile here.
Deadline for applications: June 22, 2022
March 14, 2022
BE-SAFE, EU project 2022-2027. We are recruiting 2 PhD students and 1 postdoctoral research fellow; deadline for applications: April 30, 2022.
December 20, 2021
Open position for a PhD student on persistence of intracellular infection in the team of F. Van Bambeke
Our laboratory is interested in so-called "persistent" infections, i.e. infections refractory to antibiotic treatment. More specifically, we study specific forms of infections (such as intracellular infections) and try to understand the reasons why they do not respond to antibiotic treatments.
The thesis project will aim at studying the intracellular survival of E. coli in the presence of antibiotics, in particular in in-vitro pharmacodynamic models allowing to mimic the fluctuations of antibiotic concentrations observed in-vivo (according to the pharmacokinetic profile of the drugs).
The topic of the thesis is part of a large project including laboratories of 4 Belgian universities and one laboratory in Germany. Exchanges between these laboratories are planned.
Required skills : microbiology, pharmacology, molecular and cellular biology.
Other requirements : knowledge of English, mobility between laboratories in Belgium or abroad, capacity to work in a team, autonomy and creativity.
Diploma : master (120 credits) in pharmaceutical or biomedical sciences or similar discipline; obtained with honors (> 70%)
Starting of the project : early 2022 ; financing for 4 years.
Interested? Send your CV, including your academic degrees, a cover letter and if possible a letter of recommendation before 30/12/2021 to Prof Françoise Van Bambeke (francoise.vanbambeke@uclouvain.be)
A few publications related to the project:
- Uropathogenic Escherichia coli shows antibiotic tolerance and growth heterogeneity in an in-vitro model of intracellular infection. Antimicrob Agents Chemother. 2021; 65(12):e0146821 (link here).
- Intracellular Staphylococcus aureus persisters upon antibiotic exposure. Nature Communications (2020) 11:2200 (link here)
December 10, 2021
PhD student position at UCLouvain, Brussels, Belgium - Drug delivery systems for activating the immune response against glioblastoma
The “Biomedical Magnetic Resonance” and the “Advanced Drug Delivery” research groups of the Louvain Drug Research Institute (UCLouvain, Brussels) are seeking for a PhD student with a pharmaceutical and/or biomedical background to carry out a PhD thesis on advanced drug delivery systems able to activate the immune response against glioblastoma.
This PhD position is funded by the transnational EuroNanoMed III (European Economic Community) project “Radiotherapy-Activated Immunomodulating Niches” (RAIN).
October 11, 2021
An academic position is open within the LDRI.
All the information by following the link: https://jobs.uclouvain.be/PersonnelAcademique/job/An-academic-position-in-Molecular-Pharmacology-and-Biophysics-%281-FTE%29/720743601/
March 04, 2021
The team of Medicinal Chemistry (CMFA) of the Louvain Drug Research Institute (LDRI) at UCLouvain, Brussels, Belgium, is looking for a chemical biologist to contribute to the development of chemical biology tools to probe the acyl-CoA synthetase long-chain 4 (ACSL4) enzyme and establish the potential link between ACSL4, ferroptosis and neurodegenerative diseases.
More information can be found here or obtained upon request at raphael.frederick@uclouvain.be
Please send your questions or spontaneous application at secretaire-ldri@uclouvain.be